跳到正文
原文
FiercePharma· @FiercePharma · X·· 29 天前精选AI 评分58
AI 导读

礼来Omvoh在儿童溃疡性结肠炎III期试验中取得积极结果,研究中半数儿童在治疗一年后达到临床缓解。该数据为礼来推进儿科适应症监管申报奠定基础。

推荐理由

礼来Omvoh在儿童溃疡性结肠炎III期试验中取得一年临床缓解率数据,为后续监管申报提供依据。

正文

Eli Lilly is eyeing a pediatric expansion for Omvoh after a phase 3 win in ulcerative colitis. Half of the children in the study achieved clinical remission after one year, setting the stage for regulatory filings. https://www.fiercepharma.com/pharma/eli-lillys-omvoh-takes-ph3-win-pediatric-uc $LLY

来源:FiercePharma · x.com